Surgery Partners Stock

Surgery Partners EBIT

The EBIT of Surgery Partners (SGRY) as of Aug 4, 2026 is 389.50 M USD. In the previous year, EBIT was 348.80 M USD — a change of 11.67% (higher).

EBIT

389.50 MUSD

YoY

11.67%

Last updated:

In 2026, Surgery Partners's EBIT was 389.50 M USD, a 11.67% increase from the 348.80 M USD EBIT recorded in the previous year.

The Surgery Partners EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2022
345.20 base
Jan 1, 2023
328.00 base
Jan 1, 2024
348.80 base
Jan 1, 2025
389.50 base
Jan 1, 2026 (e)
423.46 base
Jan 1, 2027 (e)
445.44 base
Jan 1, 2028 (e)
473.31 base
Jan 1, 2029 (e)
554.53 base
YEAREBIT (M USD)
2029 est 554.53
2028 est 473.31
2027 est 445.44
2026 est 423.46
2025 389.50
2024 348.80
2023 328.00
2022 345.20
2021 302.20
2020 183.00
2019 233.50
2018 77.84
2017 199.96
2016 205.68
2015 144.75
2014 50.81
2013 58.23
2012 60.45
2011 29.70
Access this data via the Eulerpool API

Surgery Partners Revenue

Surgery Partners Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
2.54 B USD
345.20 M USD
-54.60 M USD
Jan 1, 2023
2.74 B USD
328.00 M USD
-11.90 M USD
Jan 1, 2024
3.11 B USD
348.80 M USD
-168.10 M USD
Jan 1, 2025
3.31 B USD
389.50 M USD
-77.90 M USD
Jan 1, 2026 (e)
3.41 B USD
423.46 M USD
54.11 M USD
Jan 1, 2027 (e)
3.59 B USD
445.44 M USD
79.21 M USD
Jan 1, 2028 (e)
3.81 B USD
473.31 M USD
105.73 M USD
Jan 1, 2029 (e)
4.46 B USD
554.53 M USD
148.82 M USD

Surgery Partners Margins

Surgery Partners stock margins

The Surgery Partners margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Surgery Partners. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Surgery Partners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
22.64 %
13.59 %
-2.15 %
Jan 1, 2023
23.60 %
11.96 %
-0.43 %
Jan 1, 2024
23.94 %
11.20 %
-5.40 %
Jan 1, 2025
23.12 %
11.77 %
-2.35 %
Jan 1, 2026 (e)
23.12 %
12.42 %
1.59 %
Jan 1, 2027 (e)
23.12 %
12.42 %
2.21 %
Jan 1, 2028 (e)
23.12 %
12.42 %
2.77 %
Jan 1, 2029 (e)
23.12 %
12.42 %
3.33 %

Surgery Partners Stock analysis

What does Surgery Partners do? Surgery Partners Inc is an American company specializing in specialized surgical services in the United States. It was founded in 1997 and is headquartered in Nashville, Tennessee. The company focuses on outpatient surgical procedures, providing a variety of medical services including eye surgery, endoscopy, ENT surgery, gynecology, orthopedic surgery, plastic surgery, and urology. Surgery Partners has over 180 surgical centers and practices in 32 states. It expanded its services through the acquisition of Symbion Healthcare in 2017, offering anesthesia services, pain management, diagnostics, and laboratory services. The company also emphasizes excellent service and has partnerships with hospitals to expand its surgical services. Surgery Partners is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Surgery Partners's EBIT

Surgery Partners's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Surgery Partners's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Surgery Partners's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Surgery Partners’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Surgery Partners stock

EBIT of Surgery Partners is 389.50 M USD in 2026.

EBIT of Surgery Partners changed from 348.80 M USD to 389.50 M USD, representing a 11.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Surgery Partners since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Surgery Partners historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Surgery Partners

All Key Metrics — Surgery Partners